Hepatitis C Virus Of Subtype 2l In Marseille, Southeastern France
INTERVIROLOGY(2015)
摘要
The rate of eradication of chronic hepatitis C considerably increases with direct-acting antiviral agents, particularly hepatitis C virus (HCV) polymerase inhibitors. While implementing full-length HCV NS5B polymerase sequencing in our clinical microbiology laboratory, we identified atypical HCV sequences, classified as subtype 21, from 2 patients. HCV-2l NS5B polymerase sequences were detected from 5 and 14 additional patients by screening our laboratory hepatitis virus sequence database and the NCBI GenBank sequence database. Phylogenetic analyses show unambiguously that all HCV-2l sequences are clustered apart from HCV 2 non-I sequences, which compose a second cluster. Mean (+/- SD) nucleotide identity between near full-length NS5B fragments of subtype 21 was 93.4 +/- 0.8% (range: 92.4-95.1). Of note, all HCV-2l sequences obtained in our laboratory and in other centers were from serum samples collected in France. Analysis of the HCV-2l NS5B polymerase amino acid sequences at 30 positions critical for interaction with or resistance to HCV polymerase inhibitors showed specific patterns. (C) 2015 S. Karger AG, Basel
更多查看译文
关键词
Hepatitis C virus, Genotype, Subtype 2l, Treatment, Polymerase
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要